1.
Lorusso D, Marinaccio M, Mele E, Sarno I, Scambia G, Raspagliesi F. Retrospective trial on trabectedin (ET-743) monotherapy in very heavily pretreated advanced ovarian cancer:  . CBN [Internet]. 2013 Oct. 15 [cited 2024 Dec. 4];1(1):14-7. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/249